Allergan announced operating results for the quarter ended Dec. 31, with a declaration of a $0.05 per share fourth-quarter dividend, payable on March 20 to shareholders on record as of Feb. 9, according to a company press release.The company reported t…
Posterior corneal elevation, irregular astigmatism affect vision in childhood glaucoma
An increase in posterior corneal elevation and irregular astigmatism may contribute to visual disability in patients with childhood glaucoma, according to a study.The cross-sectional, observational study examined 58 eyes of patients with childhood glau…
New study shows that 25% of homeless people in Toronto have vision problems
Twenty-five per cent of homeless people surveyed in Toronto had vision problems up to and including blindness, four times higher than the rate of the overall population in North America, a new study by St. Michael’s Hospital has found.
UEMS survey highlights accessibility disparities, inconsistent policies for anti-VEGF treatment across Europe
A survey conducted across the 28 EU countries and Switzerland by the European Union of Medical Specialists highlighted a diverse and uneven scenario of anti-VEGF treatment in Europe in terms of numbers, prices, rules and policies. “These results paint a clear picture, and this is in itself an important achievement. From here, we know what has to be addressed,” Marko Hawlina, MD, PhD, vice president of the ophthalmology section of the European Union of Medical Specialists (UEMS), said.
Medicare Administrative Contractor issues proposed co-management guidelines
In September 2014, Novitas Solutions, a Medicare Administrative Contractor, issued a Proposed/Draft Local Coverage Determination for Co-management of Surgical Procedures (DL27481). The LCD specifically noted the following:This policy addresses the indi…
Top 5 ophthalmology news stories this week
Trending ophthalmology topics this week ranged from the FDA approval of two Tecnis multifocal IOLs from Abbott to the recommendation of the approval of Eylea in Europe for the treatment of macular edema secondary to retinal vein occlusion.